Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion type Assertion NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_head.
- NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion description "[A total of 232 serum and plasma samples derived from patients with chronic hepatitis C (genotype 1 [GT1], n = 108; GT2, n = 8; GT3, n = 24; GT4, n = 87; GT5, n = 3; and GT6, n = 2) were processed in parallel with the Cobas AmpliPrep/Cobas TaqMan HCV Test (CAP/CTM), Cobas Amplicor HCV Monitor Test v2.0 (CAM), and two second-version prototype formulations of CAP/CTM, Mastermix 1 (MMx1) and MMx2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_provenance.
- NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion evidence source_evidence_literature NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_provenance.
- NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion SIO_000772 21752967 NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_provenance.
- NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion wasDerivedFrom befree-20150227 NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_provenance.
- NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_assertion wasGeneratedBy ECO_0000203 NP620407.RA7KCZQUJL-uO0NuoqxYu1x3oWsvI2pVbYa6D7F1sZ6n8130_provenance.